Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/31/2025 3:40:31 PM
Board Marks: 394
Posts Today: 7
Board Views Today: 13095
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
brentie
07/02/2025 10:50:35 AM
"Third, we have finalized the protocol
(7)
Mr3Putt
07/02/2025 10:38:36 AM
IIRC, It's the Cornell trial, if it
(2)
MJS719
07/02/2025 10:24:14 AM
I noticed on the website that we did or
(1)
dfwl28
07/02/2025 9:51:11 AM
Ohm: "... Bring in a PD-L1 or PD-1
(2)
My69z
07/02/2025 9:43:44 AM
Thx SamaGong!...makes sense when you
(2)
Boatbuilder
07/02/2025 9:02:55 AM
The Morningstar mention is significant.
(2)
SamaGong
07/02/2025 8:37:15 AM
Yeah, adding ICI treatment into the mix
(3)
Plotinus
07/02/2025 8:32:29 AM
A better way of understanding protocol
(16)
Riztheinvestor
07/02/2025 8:11:36 AM
Morally negligent welp theyve
(1)
My69z
07/02/2025 7:18:22 AM
Some studies suggest that modulating
(6)
brentie
07/02/2025 7:14:48 AM
We're getting some coverage...
(24)
My69z
07/02/2025 2:14:40 AM
SK said in the 2022 video we hired a
(18)
HouseofCards
07/02/2025 1:33:23 AM
All this appears to say is that they
(2)
grow
07/02/2025 1:32:16 AM
Thank you for your insights
(1)
chazzledazzle
07/02/2025 1:22:37 AM
PD-L1 is just the perfume needed to get
(1)
chazzledazzle
07/02/2025 1:20:01 AM
This is exactly what I said but in my
(1)
ohm20
07/02/2025 1:12:34 AM
The question I think is what does he
(17)
chazzledazzle
07/02/2025 1:07:49 AM
That is correct. Expect a lag in any
(1)
ohm20
07/02/2025 12:52:05 AM
Heres the study overview. As well as
(8)
ohm20
07/02/2025 12:43:53 AM
OK , in this PR , but do you see
(24)
ohm20
07/02/2025 12:31:46 AM
PD-L1 (programmed death ligand one) is
(18)
grow
07/02/2025 12:14:41 AM
The LinkedIn post from Max carries
(10)
chazzledazzle
07/02/2025 12:14:12 AM
I hope so too. That does make it seem
(3)
Evil Rabbit
07/02/2025 12:11:21 AM
After years of doing this, I feel like
(15)
MJS719
07/01/2025 11:10:22 PM
And then in late May: MONMOUTH
(7)
MJS719
07/01/2025 11:06:31 PM
For the newbies unsure about how we
(8)
Katangolo
07/01/2025 11:02:42 PM
Always awake, always vigilant. Shorts
(1)
Katangolo
07/01/2025 10:37:49 PM
As expected. Bashers always lurking and
(8)
misiu143
07/01/2025 10:06:30 PM
On Linkedin Dr Max L commented to Ken
(11)
chazzledazzle
07/01/2025 9:38:50 PM
Heres some stuff from when we
(1)
chazzledazzle
07/01/2025 9:16:03 PM
Adding checkpoint inhibitors is not a
(2)
chazzledazzle
07/01/2025 8:57:43 PM
OK , in this PR , but do you see
(4)
Plotinus
07/01/2025 8:40:47 PM
Hints on perhaps the next shoe to drop:
(8)
john1234
07/01/2025 8:32:20 PM
I know how it works was a mode on some
Riztheinvestor
07/01/2025 7:54:12 PM
John being a mod is not an easy job
(5)
chazzledazzle
07/01/2025 7:31:49 PM
Id like to extract this statement
(5)
misiu143
07/01/2025 7:29:35 PM
OK , in this PR , but do you see
(1)
misiu143
07/01/2025 7:25:14 PM
If you talking about shareholder letter
john1234
07/01/2025 7:24:54 PM
Just so you know Im not a basher nor
(3)
chazzledazzle
07/01/2025 7:23:40 PM
We have also amended our current
(6)
chazzledazzle
07/01/2025 7:17:40 PM
Investor letter. Website. I can find it
Evil Rabbit
07/01/2025 7:15:25 PM
Plenty of other boards will allow you
(12)
chazzledazzle
07/01/2025 7:15:10 PM
Come on dude, you think we dont know
(2)
misiu143
07/01/2025 7:12:20 PM
Thank you , somehow I miss that . Was
(1)
chazzledazzle
07/01/2025 7:08:18 PM
Check Dr Js comments tgat tve
(1)
chazzledazzle
07/01/2025 7:06:09 PM
Yes
chazzledazzle
07/01/2025 6:59:44 PM
Hi surfrebel, I love your moniker,
(12)
Katangolo
07/01/2025 6:55:47 PM
Not trying to run you off Jon. But
(12)
john1234
07/01/2025 6:46:45 PM
As an investor I dont need this from
(3)
chazzledazzle
07/01/2025 6:35:46 PM
Sorry meant to include a reference from
Newer
Older
Recent Articles
Neuberger Berman Real Estate Fund Updates Monthly Distribution
Buchanan Ingersoll & Rooney Marks 175 Years of Excellence
Lily Yan Hughes Joins Allbirds Board as Independent Director
Legal Action Against Baxter International, Inc. Aims to Compensate Investors
MoonLake Immunotherapeutics Faces Securities Fraud Allegations
James Hardie Industries Faces Class Action Lawsuit for Investors
Upcoming Presentation of NN, Inc. at Annual Automotive Event
Cohen & Company Announces Q3 2025 Earnings Call Details
Analyzing the Growth of HCA Healthcare Stock: A Decade Journey
Pangaea Logistics Solutions Announces Q3 Conference Call Details
Oak Ridge Financial Services Reports Strong Q3 Performance
NB Bancorp and Provident Bancorp Set Merger Election Deadlines
ECARX Secures Major Financing to Boost Strategic Initiatives
Deadline Confirmed for NB Bancorp and Provident Merger Process
Leidos Holdings, Inc. Raises Quarterly Cash Dividend Announcement
Pangaea Logistics Solutions to Host Q3 2025 Results Call
Mary Laschinger Joins Stanley Black & Decker's Board of Directors
Spirit AeroSystems' Q3 2025 Financial Results Overview
Aberdeen Investments Announces New Distribution Payment Details
Global Engine Group Holding Limited Addresses Nasdaq Compliance Issue
Astrotech Welcomes Scott Bartley as New Interim CFO
Cohen & Company's Upcoming Financial Results Announcement
Credicorp Ltd. Prepares for Upcoming Earnings Announcement
NN, Inc. Leadership to Showcase Innovations at Upcoming Event
Cielo Waste Solutions Hosts Engaging Webinar on Project Nexus
Upcoming Launch of ViaSat-3 F2 Satellite to Enhance Services
Agencia Comercial Spirits Expands Offering with Additional Shares
Allbirds Expands Board with Appointment of Lily Yan Hughes
Glen Burnie Bancorp's Gains Mark Third Quarter Heights
TeraWulf Secures $1.025 Billion for Sustainable Data Centers
Heidmar Maritime Holdings Sets Quarterly Results and Call Schedule
Clover Health Welcomes New Chapter with Board Changes
Legence Plans Q3 Earnings Call with Key Insights Ahead
Taitron Components Increases Shareholder Value with Dividend
Organogenesis Holdings Inc. Announces Key Inducement Awards
ECARX Strengthens Board with New Appointment of Lone Schroeder
Cleveland's DigitalC Initiative Leads the Way in Broadband Access
Olympus Enhances Safety Guidelines for Bronchoscopes with Lasers
CarParts.com Reschedules Third Quarter Conference Call
Amgen Declares Fourth Quarter Dividend Highlighting Innovation
Accuray Incorporated Unveils CEO Inducement Awards Program
TransMedics Expands Team with Strategic Stock Options Grants
Otsuka ICU Medical's Important Recall of Potassium Chloride
Peoples Financial Services Corp. Announces Q4 2025 Dividend Details
Upcoming Earnings Report and Conference Call Insights
Oak Ridge Financial Services Reports Strong Q3 2025 Results
Cepton, Inc. Investors Encouraged to Take Action Before Deadline
Important Actions for Cytokinetics, Inc. Stockholders Ahead
Empowering Small Businesses: Prospera's Impact in Florida
Foresight Psychology Provides National Testing Services for Exams